BDR Research report: " . . . voters from Pharma favored Kessler and Woodcock, . . . and the general public preferred Rost

From the report:

"BDR Research engaged political and industry contacts to assemble a list of candidates they believe have a realistic chance of becoming Director of the FDA under President Obama"

#3 candidate listed was "Dr. Peter Rost former VP of Marketing Pharmacia and then at Pfizer"

" . . . voters from Pharma favored Kessler and Woodcock, while healthcare professionals preferred Nissen and the general public preferred Rost"




BDR Research Group, LLC conducts primary, fundamental research to identify and evaluate Healthcare and Industrial equities for institutional investment.

Our Goal: help our targeted client base make money, avoid losses and find actionable ideas. Quickly. Our efforts are focused on the independent development of opportunistic, actionable ideas, for a limited group of select clients.